PROSTVAC®
PROSTVAC® is a therapeutic cancer vaccine in Phase 3
clinical development.
The vaccine has the potential to significantly extend the
lives of men with advanced prostate cancer where limited treatment
options are available - without affecting their quality of
life.
PROSTVAC® also holds the promise of moving into larger
patient populations in earlier stages of the disease.
PROSTVAC® is intended for use in patients whose disease has
recurred after surgery or radiotherapy - fulfilling an unmet
medical need.
Phase 3 clinical trial information
The PROSTVAC® Phase 3 clinical trial (PROSPECT) is currently
recruiting patients. For more information, please visit:
Continueyourfight.com (for
patients)
Clinicaltrials.gov (for
professionals)
More information:
